GLP-3 (Retatrutide) is a cutting-edge investigational peptide designed to support research on metabolic health, weight management, and glucose regulation. Known as a triple hormone receptor agonist, it targets GLP-1, GIP, and glucagon receptors, offering a powerful new approach in metabolic research.
Scientific Description:
Retatrutide is a multi-agonist peptide engineered to engage GLP-1, GIP, and glucagon receptor pathways in research models. Its design allows investigation into concurrent activation of these receptors, with experimental focus on associated metabolic signaling, energy homeostasis networks, and receptor cross-talk. Retatrutide serves as a peptide tool compound for dissecting multi-pathway metabolic regulation in controlled systems.
Reviews
There are no reviews yet.